Arkolith/Insider Trading/TMDX/Form 4

Weill David

DirectorTransMedics Group, Inc. (TMDX) · full profile →Form 4 · filed May 23, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$91K
Net Open-Market Flow
-$91K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 23, 2025Sell(S)732$123.88$91K12K
May 22, 2025Grant(A)2K—$013K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-077211) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML